Literature DB >> 22179217

Escherichia coli Nissle 1917 (Mutaflor): new insights into an old probiotic bacterium.

Christoph A Jacobi1, Peter Malfertheiner.   

Abstract

Probiotic bacteria are live microorganisms which contribute health benefits to their host. The numerous mechanisms of the probiotic-acting microorganisms include the induction of expression of certain cytokines and increasing the secretion of IgA and mucin. They activate lymphocytes and macrophages and inhibit the adhesion and invasion of epithelial cells. Escherichia coli Nissle 1917 (Mutaflor) is one of the most investigated probiotic bacteria. While the number of reports discussing the underlying mechanisms of Mutaflor has increased rapidly in recent years, novel clinical studies are missing. Here we provide an overview of the mechanisms of action and clinical studies related to Mutaflor. While most of the studies had positive outcomes, there are also a few in which Mutaflor did not perform to its expectations.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 22179217     DOI: 10.1159/000333307

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  32 in total

1.  A transgenic probiotic secreting a parasite immunomodulator for site-directed treatment of gut inflammation.

Authors:  Rose A Whelan; Sebastian Rausch; Friederike Ebner; Dorothee Günzel; Jan F Richter; Nina A Hering; Jörg-Dieter Schulzke; Anja A Kühl; Ahmed Keles; Pawel Janczyk; Karsten Nöckler; Lothar H Wieler; Susanne Hartmann
Journal:  Mol Ther       Date:  2014-07-02       Impact factor: 11.454

Review 2.  Reevaluating the hype: four bacterial metabolites under scrutiny.

Authors:  E E Fröhlich; R Mayerhofer; P Holzer
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-03-26

Review 3.  The manifold roles of microbial ribosomal peptide-based natural products in physiology and ecology.

Authors:  Yanyan Li; Sylvie Rebuffat
Journal:  J Biol Chem       Date:  2019-11-29       Impact factor: 5.157

Review 4.  Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

Review 5.  No vacancy: how beneficial microbes cooperate with immunity to provide colonization resistance to pathogens.

Authors:  Martina Sassone-Corsi; Manuela Raffatellu
Journal:  J Immunol       Date:  2015-05-01       Impact factor: 5.422

6.  Intestinal-borne dermatoses significantly improved by oral application of Escherichia coli Nissle 1917.

Authors:  Elina Manzhalii; Daniel Hornuss; Wolfgang Stremmel
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

7.  Probiotic bacteria reduce salmonella typhimurium intestinal colonization by competing for iron.

Authors:  Elisa Deriu; Janet Z Liu; Milad Pezeshki; Robert A Edwards; Roxanna J Ochoa; Heidi Contreras; Stephen J Libby; Ferric C Fang; Manuela Raffatellu
Journal:  Cell Host Microbe       Date:  2013-07-17       Impact factor: 21.023

Review 8.  Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 9.  Forty Years of Oxalobacter formigenes, a Gutsy Oxalate-Degrading Specialist.

Authors:  Steven L Daniel; Luke Moradi; Henry Paiste; Kyle D Wood; Dean G Assimos; Ross P Holmes; Lama Nazzal; Marguerite Hatch; John Knight
Journal:  Appl Environ Microbiol       Date:  2021-08-26       Impact factor: 4.792

10.  Nature of bacterial colonization influences transcription of mucin genes in mice during the first week of life.

Authors:  Anders Bergström; Matilde B Kristensen; Martin I Bahl; Stine B Metzdorff; Lisbeth N Fink; Hanne Frøkiaer; Tine R Licht
Journal:  BMC Res Notes       Date:  2012-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.